Hatfield Jeffrey S.
Insider CIK 1609879 · AMBI Director · VTAE Chief Executive Officer, Director · NVIV Director · LIFE Director · ZFGN Chief Executive Officer, Director · MGEN Director · VIR Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| VIR Vir Biotechnology, Inc. | A Award deriv | 2026-05-27 | 2026-05-28 | 16,000 | — | $0 | 16,000 | SEC↗ |
| VIR Vir Biotechnology, Inc. | A Award | 2026-05-27 | 2026-05-28 | 8,000 | — | $0 | 39,806 | SEC↗ |
| VIR Vir Biotechnology, Inc. | A Award deriv | 2025-05-30 | 2025-06-02 | 16,000 | — | $0 | 16,000 | SEC↗ |
| VIR Vir Biotechnology, Inc. | A Award | 2025-05-30 | 2025-06-02 | 8,000 | — | $0 | 31,806 | SEC↗ |
| VIR Vir Biotechnology, Inc. | A Award deriv | 2024-05-30 | 2024-06-03 | 16,000 | — | $0 | 16,000 | SEC↗ |
| VIR Vir Biotechnology, Inc. | A Award | 2024-05-30 | 2024-06-03 | 8,000 | — | $0 | 23,806 | SEC↗ |
| VIR Vir Biotechnology, Inc. | A Award deriv | 2023-05-22 | 2023-05-24 | 12,054 | — | $0 | 12,054 | SEC↗ |
| VIR Vir Biotechnology, Inc. | A Award | 2023-05-22 | 2023-05-24 | 6,027 | — | $0 | 15,806 | SEC↗ |
| VIR Vir Biotechnology, Inc. | A Award deriv | 2022-05-23 | 2022-05-25 | 12,810 | — | $0 | 12,810 | SEC↗ |
| VIR Vir Biotechnology, Inc. | A Award | 2022-05-23 | 2022-05-25 | 6,405 | — | $0 | 9,779 | SEC↗ |
| VIR Vir Biotechnology, Inc. | A Award deriv | 2021-05-21 | 2021-05-25 | 6,748 | — | $0 | 6,748 | SEC↗ |
| VIR Vir Biotechnology, Inc. | A Award | 2021-05-21 | 2021-05-25 | 3,374 | — | $0 | 3,374 | SEC↗ |
| VRDN Viridian Therapeutics, Inc | A Award deriv | 2021-02-04 | 2021-02-08 | 25,000 | — | $0 | 25,000 | SEC↗ |
| VIR Vir Biotechnology, Inc. | A Award deriv | 2020-12-09 | 2020-12-11 | 46,500 | — | $0 | 46,500 | SEC↗ |
| MGEN MIRAGEN THERAPEUTICS, INC. | A Award deriv | 2020-05-21 | 2020-05-22 | 24,000 | — | $0 | 24,000 | SEC↗ |
| LIFE aTYR PHARMA INC | A Award deriv | 2020-05-06 | 2020-05-08 | 1,428 | — | $0 | 1,428 | SEC↗ |
| MGEN MIRAGEN THERAPEUTICS, INC. | A Award deriv | 2019-06-19 | 2019-06-21 | 12,000 | — | $0 | 12,000 | SEC↗ |
| LIFE aTYR PHARMA INC | A Award deriv | 2019-05-08 | 2019-05-10 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ZFGN ZAFGEN, INC. | A Award deriv | 2019-01-22 | 2019-01-24 | 525,000 | — | $0 | 525,000 | SEC↗ |
| MGEN MIRAGEN THERAPEUTICS, INC. | A Award deriv | 2018-06-27 | 2018-06-28 | 12,000 | — | $0 | 12,000 | SEC↗ |
| LIFE aTYR PHARMA INC | A Award deriv | 2018-05-15 | 2018-05-17 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ZFGN ZAFGEN, INC. | A Award deriv | 2018-02-22 | 2018-02-23 | 275,000 | — | $0 | 275,000 | SEC↗ |
| NVIV INVIVO THERAPEUTICS HOLDIN | A Award deriv | 2018-01-19 | 2018-01-23 | 12,500 | — | $0 | 12,500 | SEC↗ |
| ZFGN ZAFGEN, INC. | A Award deriv | 2017-12-29 | 2017-12-29 | 1,100,000 | — | $0 | 1,100,000 | SEC↗ |
| ZFGN ZAFGEN, INC. | A Award deriv | 2017-10-09 | 2017-10-11 | 550,000 | — | $0 | 550,000 | SEC↗ |
| LIFE aTYR PHARMA INC | A Award deriv | 2017-05-09 | 2017-05-11 | 20,000 | — | $0 | 20,000 | SEC↗ |
| LIFE aTYR PHARMA INC | A Award deriv | 2017-04-03 | 2017-04-04 | 32,000 | — | $0 | 32,000 | SEC↗ |
| NVIV INVIVO THERAPEUTICS HOLDIN | A Award deriv | 2016-11-01 | 2016-11-03 | 25,000 | — | $0 | 25,000 | SEC↗ |
| VTAE Vitae Pharmaceuticals, Inc | D To issuer deriv | 2016-10-25 | 2016-10-25 | 26,086 | $17.55 | $457.8K | 0 | SEC↗ |
| VTAE Vitae Pharmaceuticals, Inc | D To issuer deriv | 2016-10-25 | 2016-10-25 | 60,000 | $12.22 | $733.2K | 0 | SEC↗ |
| VTAE Vitae Pharmaceuticals, Inc | D To issuer deriv | 2016-10-25 | 2016-10-25 | 60,000 | $12.42 | $745.2K | 0 | SEC↗ |
| VTAE Vitae Pharmaceuticals, Inc | D To issuer deriv | 2016-10-25 | 2016-10-25 | 50,000 | $12.72 | $636.0K | 0 | SEC↗ |
| VTAE Vitae Pharmaceuticals, Inc | D To issuer deriv | 2016-10-25 | 2016-10-25 | 50,000 | $6.60 | $330.0K | 0 | SEC↗ |
| VTAE Vitae Pharmaceuticals, Inc | D To issuer deriv | 2016-10-25 | 2016-10-25 | 134,782 | $13.87 | $1.87M | 0 | SEC↗ |
| VTAE Vitae Pharmaceuticals, Inc | D To issuer deriv | 2016-10-25 | 2016-10-25 | 10,320 | $14.10 | $145.5K | 0 | SEC↗ |
| VTAE Vitae Pharmaceuticals, Inc | D To issuer deriv | 2016-10-25 | 2016-10-25 | 20,869 | $17.09 | $356.7K | 0 | SEC↗ |
| VTAE Vitae Pharmaceuticals, Inc | D To issuer deriv | 2016-10-25 | 2016-10-25 | 6,245 | $17.09 | $106.7K | 0 | SEC↗ |
| VTAE Vitae Pharmaceuticals, Inc | D To issuer deriv | 2016-10-25 | 2016-10-25 | 30,434 | $17.55 | $534.1K | 0 | SEC↗ |
| VTAE Vitae Pharmaceuticals, Inc | U Tender | 2016-10-24 | 2016-10-25 | 244,996 | $21.00 | $5.14M | 244,996 | SEC↗ |
| VTAE Vitae Pharmaceuticals, Inc | S Sale | 2016-09-14 | 2016-09-16 | 50,000 | $20.81 | $1.04M | 244,996 | SEC↗ |
| VTAE Vitae Pharmaceuticals, Inc | A Award deriv | 2016-08-15 | 2016-08-17 | 60,000 | — | $0 | 60,000 | SEC↗ |
| VTAE Vitae Pharmaceuticals, Inc | A Award | 2016-04-29 | 2016-08-17 | 747 | $6.11 | $4.6K | 294,996 | SEC↗ |
| VTAE Vitae Pharmaceuticals, Inc | A Award deriv | 2016-02-15 | 2016-02-16 | 60,000 | — | $0 | 60,000 | SEC↗ |
| VTAE Vitae Pharmaceuticals, Inc | M Exercise | 2015-12-28 | 2016-01-25 | 26,537 | $3.45 | $91.6K | 294,249 | SEC↗ |
| VTAE Vitae Pharmaceuticals, Inc | M Exercise deriv | 2015-12-28 | 2015-12-28 | 26,537 | — | $0 | 0 | SEC↗ |
| VTAE Vitae Pharmaceuticals, Inc | M Exercise | 2015-12-28 | 2015-12-28 | 26,537 | $3.45 | $91.6K | 293,897 | SEC↗ |
| VTAE Vitae Pharmaceuticals, Inc | M Exercise deriv | 2015-12-23 | 2015-12-28 | 16,940 | — | $0 | 0 | SEC↗ |
| VTAE Vitae Pharmaceuticals, Inc | M Exercise deriv | 2015-12-23 | 2015-12-28 | 5,584 | — | $0 | 0 | SEC↗ |
| VTAE Vitae Pharmaceuticals, Inc | M Exercise | 2015-12-23 | 2015-12-28 | 5,584 | $3.45 | $19.3K | 272,944 | SEC↗ |
| VTAE Vitae Pharmaceuticals, Inc | M Exercise | 2015-12-23 | 2015-12-28 | 16,940 | $3.45 | $58.4K | 289,884 | SEC↗ |
| VTAE Vitae Pharmaceuticals, Inc | S Sale | 2015-12-23 | 2015-12-28 | 22,524 | $17.00 | $382.9K | 267,360 | SEC↗ |
| VTAE Vitae Pharmaceuticals, Inc | F Tax w/h | 2015-03-13 | 2015-03-17 | 171,156 | $11.16 | $1.91M | 267,360 | SEC↗ |
| VTAE Vitae Pharmaceuticals, Inc | M Exercise deriv | 2015-03-06 | 2015-03-09 | 8,115 | $1.15 | $9.3K | 0 | SEC↗ |
| VTAE Vitae Pharmaceuticals, Inc | M Exercise | 2015-03-06 | 2015-03-09 | 8,115 | $1.15 | $9.3K | 438,516 | SEC↗ |
| VTAE Vitae Pharmaceuticals, Inc | A Award deriv | 2015-02-13 | 2015-02-18 | 50,000 | — | $0 | 50,000 | SEC↗ |
| VTAE Vitae Pharmaceuticals, Inc | M Exercise deriv | 2015-01-22 | 2015-01-26 | 8,115 | — | $0 | 0 | SEC↗ |
| VTAE Vitae Pharmaceuticals, Inc | M Exercise deriv | 2015-01-22 | 2015-01-26 | 30,982 | — | $0 | 0 | SEC↗ |
| VTAE Vitae Pharmaceuticals, Inc | M Exercise | 2015-01-22 | 2015-01-26 | 8,115 | $1.15 | $9.3K | 399,419 | SEC↗ |
| VTAE Vitae Pharmaceuticals, Inc | M Exercise | 2015-01-22 | 2015-01-26 | 30,982 | $1.15 | $35.6K | 430,401 | SEC↗ |
| AMBI AMBIT BIOSCIENCES CORP | D To issuer deriv | 2014-11-10 | 2014-11-12 | 14,000 | $8.31 | $116.3K | 0 | SEC↗ |
| AMBI AMBIT BIOSCIENCES CORP | A Award deriv | 2014-06-02 | 2014-06-04 | 14,000 | — | $0 | 14,000 | SEC↗ |